Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 01, 2017 08:00 ET | Source: Foamix, Ltd.

Foamix Pharmaceuticals Third Quarter Financial Results Conference Call & Webcast Scheduled for November 15, 2017

REHOVOT, Israel, and BRIDGEWATER, N.J., Nov. 01, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on...
August 08, 2017 16:01 ET | Source: Foamix, Ltd.

Foamix Reports Second Quarter 2017 Financial Results and Provides Business Update

REHOVOT, Israel, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company focused on...
July 26, 2017 08:00 ET | Source: Foamix, Ltd.

Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for August 9

REHOVOT, Israel and BRIDGEWATER, N.J., July 26, 2017 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix”), a clinical stage specialty pharmaceutical company focused on...
September 06, 2016 08:00 ET | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at the Rodman & Renshaw 18th Annual Global Investment Conference

REHOVOT, Israel and BRIDGEWATER, N.J., Sept. 06, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
August 10, 2016 07:00 ET | Source: Foamix, Ltd.

Foamix Reports Second Quarter 2016 Financial Results and Provides Business Update

REHOVOT, Israel, Aug. 10, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) (“Foamix Pharmaceuticals” or the “Company”), a clinical stage specialty pharmaceutical company...
July 25, 2016 08:00 ET | Source: Foamix, Ltd.

Foamix Pharmaceuticals Second Quarter Financial Results Conference Call & Webcast Scheduled for Wednesday, August 10

REHOVOT, Israel and BRIDGEWATER, N.J., July 25, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company...
June 01, 2016 08:00 ET | Source: Foamix, Ltd.

Foamix to Present at the BIO International Convention

REHOVOT, Israel and BRIDGEWATER, N.J., June 01, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), (“Foamix Pharmaceuticals”), a clinical stage specialty pharmaceutical company...
May 31, 2016 08:00 ET | Source: Foamix, Ltd.

Foamix Pharmaceuticals Announces Publication of Abstract on FDX-104 in the Treatment of EGFRI Induced Rash for the 2016 ASCO Meeting

REHOVOT, Israel and BRIDGEWATER, N.J., May 31, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
May 26, 2016 08:00 ET | Source: Foamix, Ltd.

Foamix to Present Corporate Overview at the Jefferies 2016 Healthcare Conference

REHOVOT, Israel and BRIDGEWATER, N.J., May 26, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...
May 16, 2016 08:00 ET | Source: Foamix, Ltd.

Foamix Names Dr. Stanley Hirsch as Chairman, and Dr. Dalia Megiddo as a Member of the Board of Foamix Pharmaceuticals

REHOVOT, Israel and BRIDGEWATER, N.J., May 16, 2016 (GLOBE NEWSWIRE) -- Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX), a clinical stage specialty pharmaceutical company focused on developing and...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right